One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood.v124.21.4741.4741
Copy DOI Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 15 |
Affiliation: Hackensack University Medical Center, Cheyney University of Pennsylvania, Oregon Health & Science University, Emory University, Boston University, City of Hope, Tufts Medical Center, Cancer Prevention Institute of California, Memorial Sloan Kettering Cancer Center, Columbia University, Cedars-Sinai Medical Center, Duke Medical CenterA Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
